Elevance Health, Inc. (ELV) operating KPIs
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)
Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –
Elevance Health carelonRx Segment — Total Operating Revenue ($M)
Annual figures from Elevance Health's filings and investor materials
Latest, FY2025
43,400
Period ended Dec 31, 2025
Change on a year earlier
+20.7%
35,961 in FY2024
History
7 years
Since FY2019
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CarelonRx Segment — Total Operating Revenue ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 43,400 | +20.7% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| FY2024 | Dec 31, 2024 | 35,961 | +6.3% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| FY2023 | Dec 31, 2023 | 33,835 | +18.6% | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| FY2022 | Dec 31, 2022 | 28,526 | +12.2% | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| FY2021 | Dec 31, 2021 | 25,431 | +16.1% | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| FY2020 | Dec 31, 2020 | 21,911 | +305.6% | 8-K ER (FY2021Q4, 2022-01-26) ↗ |
| FY2019 | Dec 31, 2019 | 5,402 | – | 8-K ER (FY2020Q4, 2021-01-27) ↗ |
Breakdown
What makes up carelonrx segment — total operating revenue
Cite this data
StockData. (2026). Elevance Health CarelonRx Segment — Total Operating Revenue ($M), annual FY2019–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg_rev_carelonrx
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.